Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
Holders of 5% or more of CTIC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cti Biopharma Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Cti Biopharma Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Cti Biopharma Corp, newest first.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 15, 2021 | Biotechnology Value Fund L P | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Caxton Corp | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cti Biopharma Corp shares.
No Form 144 notices for Cti Biopharma Corp are on file.